• Home |
• Demo Center |
• Success Center |
• Careers |
• Contact Us

Verticals onDemand customers are industry leaders and innovators, ranging from the world's largest pharmaceutical companies to biotechs hiring their very first sales teams. At our first several customers, Verticals onDemand has replaced Dendrite, StayInFront, and custom built systems, proving that the onDemand model is far superior to legacy client/server applications. The future of Pharma CRM is here today.

	Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products, primarily in the fields of urology and endocrinology. With a robust and diversified pipeline, Indevus is becoming an emerging leader in urology and endocrinology.
	Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) is a leading biopharmaceutical company based in Cambridge, Mass. Millennium markets a novel cancer product and has a robust clinical development pipeline of product candidates.
	ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets.
VoD Success Story	Publicis Managed Markets (PMM) offers the biopharmaceutical industry comprehensive managed markets solutions including strategy, tactics, and execution services across all managed markets channels. PMM provides emerging pharma and biotech companies with the expertise needed to impact managed markets channels for early product commercialization, as well as delivering coverage for under-represented brands in Big Pharma through end-stages of the product lifecycle.
	Solstice Neurosciences, Inc. is an emerging specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product, Myobloc®/Neurobloc®, represents the only botulinum toxin type B currently available to physicians and patients worldwide.